We are live on ! Find out more
NCCM

Nine Chapters Capital Management Portfolio holdings

AUM $45.4M
1-Year Est. Return 14.43%
This Fund
S&P 500
This Quarter Est. Return
+2.63%
1 Year Est. Return
+14.43%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$74.2M
AUM Growth
+$15M
Cap. Flow
+$14.4M
Cap. Flow %
19.36%
Top 10 Hldgs %
13.06%
Holding
348
New
176
Increased
42
Reduced
20
Closed
110

Top Buys

Rank Stock Value
1
ANIK icon
Anika Therapeutics
ANIK
+$1.21M
2
PBI icon
Pitney Bowes
PBI
+$1.09M
3
SNPS icon
Synopsys
SNPS
+$1.04M
4
LMNX
Luminex Corp
LMNX
+$1.03M
5
AGCO icon
AGCO
AGCO
+$948K

Top Sells

Rank Stock Value
1
XRX icon
Xerox
XRX
+$1.2M
2
PPL
PPL Corp
PPL
+$1.09M
3
DF
Dean Foods Company
DF
+$1.09M
4
FE icon
FirstEnergy
FE
+$1.09M
5
GILD icon
Gilead Sciences
GILD
+$1.09M

Sector Composition

Rank Sector Weight
1 Industrials 20%
2 Healthcare 16.95%
3 Technology 13.59%
4 Consumer Discretionary 11.18%
5 Financials 6.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JRVR icon
151
James River Group Holdings
JRVR
$208M
$210K 0.28%
+4,900
New +$203K
CNC icon
152
Centene
CNC
$30.7B
$207K 0.28%
5,800
-11,400
-66% -$382K
USNA icon
153
Usana Health Sciences
USNA
$408M
$207K 0.28%
+3,600
New +$215K
INWK
154
DELISTED
InnerWorkings, Inc.
INWK
$207K 0.28%
+20,800
New +$201K
BURL icon
155
Burlington
BURL
$23.2B
$204K 0.28%
+2,100
New +$186K
FOE
156
DELISTED
Ferro Corporation
FOE
$204K 0.28%
+13,400
New +$192K
EMN icon
157
Eastman Chemical
EMN
$8B
$202K 0.27%
2,500
-12,000
-83% -$944K
NBIS
158
Nebius Group N.V.
NBIS
$48.3B
$202K 0.27%
+9,200
New +$210K
HTB
159
HomeTrust Bancshares
HTB
$860M
$202K 0.27%
+8,600
New +$211K
TFIN icon
160
Triumph Financial Inc
TFIN
$1.81B
$201K 0.27%
+7,800
New +$207K
LRFC
161
DELISTED
Logan Ridge Finance Corp
LRFC
$200K 0.27%
+2,317
New +$195K
FONR
162
DELISTED
Fonar
FONR
$197K 0.27%
+11,200
New +$211K
LCTX icon
163
Lineage Cell Therapeutics
LCTX
$269M
$196K 0.26%
+65,037
New +$185K
TRIB
164
Trinity Biotech
TRIB
$7.83M
$183K 0.25%
+205
New +$192K
CTIC
165
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$183K 0.25%
43,500
+41,780
+2,429% +$193K
CLS icon
166
Celestica
CLS
$38.1B
$180K 0.24%
12,400
-11,900
-49% -$159K
JE
167
DELISTED
Just Energy Group Inc
JE
$177K 0.24%
+858
New +$165K
CHK
168
DELISTED
Chesapeake Energy Corporation
CHK
$177K 0.24%
149
+13
+10% +$15.8K
FCRD
169
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
$176K 0.24%
+17,700
New +$181K
WLB
170
DELISTED
Westmoreland Coal Company
WLB
$174K 0.23%
12,000
-20,100
-63% -$320K
XRX icon
171
Xerox
XRX
$387M
$173K 0.23%
5,900
-41,689
-88% -$1.2M
LRMR icon
172
Larimar Therapeutics
LRMR
$397M
$170K 0.23%
+3,033
New +$151K
GPK icon
173
Graphic Packaging
GPK
$3.17B
$167K 0.23%
13,000
-2,800
-18% -$36.4K
TAST
174
DELISTED
Carrols Restaurant Group, Inc.
TAST
$167K 0.23%
+11,800
New +$176K
ITCI
175
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$166K 0.22%
+10,200
New +$148K
5 6
7
8 9

Similar funds

CZPM
Capital Z Partners Management New York $47.4M AUM 35.48% 1-Year Est. Return
PVMCV
Polaris Venture Management Co VI Boston, Massachusetts $43.1M AUM 78.12% 1-Year Est. Return
DAC
Dymon Asia Capital Singapore $48.4M AUM 73.84% 1-Year Est. Return
TCM
Trishield Capital Management New York $40.3M AUM
SAC
SPQ Asia Capital Hong Kong $37.7M AUM 121.14% 1-Year Est. Return
PCP
Proprium Capital Partners Stamford, Connecticut $54M AUM 7.85% 1-Year Est. Return
TSP
Tappan Street Partners Chicago, Illinois $35.7M AUM 42.68% 1-Year Est. Return
A
Aetna Hartford, Connecticut $35.3M AUM 7.55% 1-Year Est. Return

Nine Chapters Capital Management's Q1 2017 Portfolio in Review

As of Q1 2017, Nine Chapters Capital Management held 348 positions worth $74.2M, up 25% from $59.1M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Nine Chapters Capital Management deployed $14.4M of net new capital in Q1 2017, opening 176 new positions and adding to 42 existing holdings. Its largest new stake was Anika Therapeutics: 25,300 shares worth $1.1M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Xerox, an estimated $1.2M trimmed.

  • Nine Chapters Capital Management's largest Q1 2017 buy was Anika Therapeutics: 25,300 shares worth $1.1M.
  • Nine Chapters Capital Management added most to RR Donnelley & Sons Co. in Q1 2017, an estimated $648K increase.
  • Nine Chapters Capital Management's biggest Q1 2017 reduction was Xerox, cutting an estimated $1.2M.
  • Nine Chapters Capital Management fully exited PPL Corp in Q1 2017, selling an estimated $1.09M.
  • Nine Chapters Capital Management's ten largest holdings make up 13% of its $74.2M portfolio in Q1 2017.
  • Nine Chapters Capital Management opened 176 new positions and closed 110 in Q1 2017.
  • Nine Chapters Capital Management's portfolio value rose 25% quarter-over-quarter to $74.2M.

Based on Nine Chapters Capital Management's 13F filing for Q1 2017, filed 8 May 2017.